Discovery of novel markers in allergic lung inflammation through proteomic-based technologies
Authors:
- Farrah KheradmandFKFarrah Kheradmand
- David B CorryDCDavid B Corry
- 1 February 2008
- journal article
- Published by Taylor & Francis in Expert Review of Proteomics
- Vol. 5 (1) , 9-12
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- A new mechanism regulating the initiation of allergic airway inflammationJournal of Allergy and Clinical Immunology, 2007
- Matrix Metalloproteinases in Lung: Multiple, Multifarious, and MultifacetedPhysiological Reviews, 2007
- Proteomic analysis of inflammatory biomarkers in bronchoalveolar lavageProteomics, 2006
- Nitric Oxide and Posttranslational Modification of the Vascular ProteomeArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Albumin depletion of human plasma also removes low abundance proteins including the cytokinesProteomics, 2005
- Asthma epidemiology: has the crisis passed?Current Opinion in Pulmonary Medicine, 2005
- Asthma: Mechanisms of Disease Persistence and ProgressionAnnual Review of Immunology, 2004
- Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokinesThe FASEB Journal, 2004
- Decreased allergic lung inflammatory cell egression and increased susceptibility to asphyxiation in MMP2-deficiencyNature Immunology, 2002
- Expression of the Ym2 Lectin-binding Protein Is Dependent on Interleukin (IL)-4 and IL-13 Signal TransductionJournal of Biological Chemistry, 2001